ch.oddb.org 
German | English | French
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Betmiga 50 mg, Retardtabletten - 30 Tablette(n)
62755005 PPAstellas Pharma AG
Betmiga 50 mg, Retardtabletten19.05.2014
  19.05.2014
Mirabegron (G04BD12) 
WHO-DDD 
50000.30 Tablette(n)
05.02. 
B  
Yes 
IPCI
34.22No
    
10 %53.65
7680627550053Synthetika
6005033 
Composition
mirabegronum 50 mg, macrogolum 2'000'000, macrogolum 8000, hydroxypropylcellulosum, E 321, magnesii stearas, Überzug: hypromellosum, macrogolum 8000, E 172 (flavum), pro compresso obducto.
Packungsbestandteile
Delayed release tablets 
 
Active AgentDose
Mirabegronum50 mg
BAG: Active AgentDose
Mirabegronum50 mg
 
Inactive agentsDoseadditional_information
(Flavum)  
E 172 color.
E 321  
Hydroxypropylcellulosum  
Hypromellosum Überzug
Macrogol8000  
Magnesii Stearas  
Pro Compresso Obducto  
 
Source
Data was imported : 06.05.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home